LU85248A1 - Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant Download PDF

Info

Publication number
LU85248A1
LU85248A1 LU85248A LU85248A LU85248A1 LU 85248 A1 LU85248 A1 LU 85248A1 LU 85248 A LU85248 A LU 85248A LU 85248 A LU85248 A LU 85248A LU 85248 A1 LU85248 A1 LU 85248A1
Authority
LU
Luxembourg
Prior art keywords
formula
group
ppm
compound
thiazolidine
Prior art date
Application number
LU85248A
Other languages
English (en)
French (fr)
Inventor
Harsanyi Kalman
Ezer Elemer
Domany Gyoergy
Szporny Laszlo
Matuz Judit
Hegedues Bela
Pallagi Katalin
Szabadkai Istvan
Tetenyi Peter
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of LU85248A1 publication Critical patent/LU85248A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU85248A 1983-03-16 1984-03-14 Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant LU85248A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU83888A HU188852B (en) 1983-03-16 1983-03-16 Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
HU88883 1983-03-16

Publications (1)

Publication Number Publication Date
LU85248A1 true LU85248A1 (fr) 1985-10-14

Family

ID=10951891

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85248A LU85248A1 (fr) 1983-03-16 1984-03-14 Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (32)

Country Link
US (1) US4616025A (de)
JP (1) JPS59196877A (de)
KR (1) KR840008001A (de)
AT (1) AT383596B (de)
AU (1) AU559753B2 (de)
BE (1) BE899132A (de)
CA (1) CA1273933A (de)
CH (1) CH660592A5 (de)
CS (1) CS241074B2 (de)
DD (1) DD216929A5 (de)
DE (1) DE3409801A1 (de)
DK (1) DK143284A (de)
ES (2) ES530738A0 (de)
FI (1) FI79843C (de)
FR (1) FR2542740B1 (de)
GB (1) GB2140412B (de)
GR (1) GR81883B (de)
HU (1) HU188852B (de)
IE (1) IE57101B1 (de)
IL (1) IL71249A (de)
IN (1) IN157738B (de)
IT (1) IT1196048B (de)
LU (1) LU85248A1 (de)
NL (1) NL8400817A (de)
NO (1) NO162858C (de)
NZ (1) NZ207516A (de)
PL (2) PL142909B1 (de)
PT (1) PT78260B (de)
SE (1) SE455945B (de)
SU (2) SU1240355A3 (de)
YU (1) YU47384A (de)
ZA (1) ZA841938B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051184A (ja) * 1983-08-30 1985-03-22 Fujimoto Seiyaku Kk Ν−シアノイミノチアゾリジン誘導体およびその製造法
JPH0730070B2 (ja) * 1985-10-03 1995-04-05 日本バイエルアグロケム株式会社 新規複素環式化合物
JPH0649699B2 (ja) * 1985-02-04 1994-06-29 日本バイエルアグロケム株式会社 ニトロメチレン誘導体、その製法及び殺虫剤
ATE67493T1 (de) * 1985-02-04 1991-10-15 Bayer Agrochem Kk Heterocyclische verbindungen.
US5001138B1 (en) * 1985-02-04 1998-01-20 Bayer Agrochem Kk Heterocyclic compounds
US5204360A (en) * 1985-02-04 1993-04-20 Nihon Bayer Agrochem K.K. Heterocyclic compounds
JPH066585B2 (ja) * 1985-02-04 1994-01-26 日本バイエルアグロケム株式会社 ニトロメチレン誘導体、その製法及び殺虫剤
USRE39130E1 (en) 1986-03-07 2006-06-13 Bayer Cropscience K.K. Heterocyclic compounds
JPH0717621B2 (ja) 1986-03-07 1995-03-01 日本バイエルアグロケム株式会社 新規ヘテロ環式化合物
JP2607369B2 (ja) * 1987-02-20 1997-05-07 興和株式会社 新規な複素環化合物
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
EP0478694B1 (de) * 1989-06-21 1997-01-15 The Trustees Of The University Of Pennsylvania Verwendung von Pirenzepine, Telenzepine oder O-Methoxy -sila-hexocyclium zur Herstellung eines Medikaments zur BEHANDLUNG UND REGULIERUNG DER AUGENENTWICKLUNG
HU207047B (en) * 1989-11-07 1993-03-01 Richter Gedeon Vegyeszet Process for producing new pyridine derivatives and pharmaceutical copositions comprising same
CA2063865A1 (en) * 1992-03-24 1993-09-25 Karoly Lempert 2-(substituted imino)-thiazolidines and process for the preparation thereof
JP2721805B2 (ja) * 1994-07-22 1998-03-04 日本バイエルアグロケム株式会社 新規ヘテロ環式化合物
DE4427539A1 (de) * 1994-08-04 1996-02-08 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von 2-Cyaniminothiazolidin
DE4427569A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Verfahren zur Herstellung von Cyanimino-1,3-thiazolidin
DE19904310A1 (de) * 1999-01-28 2000-08-03 Bayer Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CA2366260A1 (en) * 1999-03-05 2000-09-14 Masahiro Imoto Heterocyclic compounds having effect of activating .alpha.4.beta.2 nicotinic acetylcholine receptors
NZ529615A (en) * 2001-05-25 2005-07-29 Valley Forge Pharmaceuticals Pirenzepine ophthalmic gel
US7767701B2 (en) * 2002-11-22 2010-08-03 Glaxosmithkline Llc Chemical compounds
CA2521606A1 (en) * 2003-04-07 2004-10-21 Cortical Pty Ltd. Novel methods for the treatment of inflammatory diseases
US8309733B2 (en) 2008-07-01 2012-11-13 Meji Seika Pharma Co., Ltd. Imino derivatives, methods for producing the same and insecticides containing the same
MX357595B (es) * 2011-09-02 2018-07-16 Bayer Ip Gmbh Procedimiento para preparar [3-[(6-cloro-3-piridinil)metil]-2-tiaz olidiniliden]cianamida.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3264316A (en) * 1963-09-18 1966-08-02 Res Lab Dr C Janssen N V Certain 2-acylimino-3-substitutedthiazoline-4 compounds
DE2205745A1 (de) * 1972-02-08 1973-08-23 Thomae Gmbh Dr K Neue durch den n-cyaniminorest substituierten heterocyclen und verfahren zu ihrer herstellung
US4006156A (en) * 1975-06-27 1977-02-01 Shell Oil Company 3-Alkyl-2-(nitromethylene) thiazolidine
NL7704322A (nl) * 1976-05-03 1977-11-07 Merck & Co Inc Werkwijze voor het bereiden van 2-iminothiazo- lidinen en -thiazolinen.
JPS57171986A (en) * 1981-04-14 1982-10-22 Taiho Yakuhin Kogyo Kk Heterocylic ring compound containing sulfur
JPS5823682A (ja) * 1981-08-03 1983-02-12 Santen Pharmaceut Co Ltd 複素五員環化合物
DE3133918A1 (de) * 1981-08-27 1983-03-17 Bayer Ag, 5090 Leverkusen 2-arylhydrazino-2-thiazoline, acylderivate derselben, 2-arylazo-2-thiazoline, herstellungsverfahren und ihre verwendung zur bekaempfung von ekto- und endoparasiten
JPS58222886A (ja) * 1982-06-19 1983-12-24 Ricoh Co Ltd 感熱記録シ−ト
JPS5933267A (ja) * 1982-08-19 1984-02-23 Fujimoto Seiyaku Kk グアニジン誘導体およびその製造法

Also Published As

Publication number Publication date
BE899132A (fr) 1984-09-12
IE840655L (en) 1984-09-16
NL8400817A (nl) 1984-10-16
GB8406790D0 (en) 1984-04-18
DK143284A (da) 1984-09-17
ES8601170A1 (es) 1985-11-01
ATA88284A (de) 1986-12-15
IT1196048B (it) 1988-11-10
AU2583384A (en) 1984-09-20
NO162858B (no) 1989-11-20
CH660592A5 (de) 1987-05-15
SE8401463L (sv) 1984-09-17
SU1240356A3 (ru) 1986-06-23
US4616025A (en) 1986-10-07
GR81883B (de) 1984-12-12
FI79843C (fi) 1990-03-12
KR840008001A (ko) 1984-12-12
NO162858C (no) 1990-02-28
FR2542740B1 (fr) 1987-02-20
CS241074B2 (en) 1986-03-13
AT383596B (de) 1987-07-27
ZA841938B (en) 1985-05-29
FR2542740A1 (fr) 1984-09-21
HU188852B (en) 1986-05-28
ES530738A0 (es) 1985-11-01
SE455945B (sv) 1988-08-22
FI841066A0 (fi) 1984-03-16
DK143284D0 (da) 1984-02-29
CS188584A2 (en) 1985-06-13
IL71249A (en) 1987-02-27
YU47384A (de) 1986-10-31
PT78260A (en) 1984-04-01
SE8401463D0 (sv) 1984-03-15
IL71249A0 (en) 1984-06-29
JPS59196877A (ja) 1984-11-08
PL246683A1 (en) 1985-07-16
FI79843B (fi) 1989-11-30
DE3409801A1 (de) 1984-09-20
IE57101B1 (en) 1992-04-22
DD216929A5 (de) 1985-01-02
PL252129A1 (en) 1985-11-19
AU559753B2 (en) 1987-03-19
IT8420057A0 (it) 1984-03-15
GB2140412B (en) 1987-02-11
PL142909B1 (en) 1987-12-31
IN157738B (de) 1986-05-31
SU1240355A3 (ru) 1986-06-23
NZ207516A (en) 1986-06-11
NO841002L (no) 1984-09-17
GB2140412A (en) 1984-11-28
CA1273933A (en) 1990-09-11
FI841066A (fi) 1984-09-17
PL142749B1 (en) 1987-11-30
PT78260B (en) 1986-04-30
ES544286A0 (es) 1986-01-16
ES8604179A1 (es) 1986-01-16

Similar Documents

Publication Publication Date Title
LU85248A1 (fr) Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant
EP0281459A1 (de) Rechtsdrehendes Enantiomer von alpha-(4,5,6,7-Tetrahydrothieno[3,2-c]pyrid-5-yl)(2-chlorphenyl)methylacetat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen
FR2669336A1 (fr) Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
IE49902B1 (en) 4-substituted-3-hydroxy-3-pyrroline-2,5-dione compounds,process for their preparation and pharmaceutical compositions containing the same
JP2517725B2 (ja) 1H,3H−ピロロ〔1,2−c〕チアゾ−ル誘導体、その製造法および薬としての用途
CH655114A5 (fr) Derives de l'imidazotetrazinone, leur preparation et compositions pharmaceutiques les contenant.
SK103093A3 (en) New active compounds
FI84057C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva fluorallylaminderivat.
FR2464254A1 (fr) Acides oxoimidazolinalcanoiques, leurs sels et esters, procede pour leur preparation et medicaments qui les contiennent
CH633010A5 (fr) Derives de l'isoquinoleine, leur preparation et medicament qui les contient.
LU83713A1 (fr) Derives de la pyrimidine,leur procede de preparation et les compositions pharmaceutiques les contenant
CA1092120A (fr) Derives de l'hydroxy-4 thiazolidine thione-2, leur preparation et les compositions qui les contiennent
EP0238401B1 (de) Diarylmethan-Sulfonamid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0070753A1 (de) 10-(Aza-1-bicyclo(2,2,2)octyl-3)-10H-Phenothiazin-sulfonamid-2, und seine Derivate
JPS6191172A (ja) 2‐ピリジン‐チオール誘導体、その製造方法およびそれを含有する医薬組成物
EP0362006A1 (de) Chinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
FR2572405A1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation
EP0135489A1 (de) Benzofuranderivate, ihre Herstellung und ihre therapeutische Verwendung
BE898403A (fr) Nouveaux derives d'ethene-diamine et de guanidine.
BE806848A (fr) Medicament a base d'un derive de la quinoleine
EP0382628A1 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen
EP1551821B1 (de) 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten-1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie
US3954984A (en) Triazolocycloalkylthiadiazine derivatives
LU86706A1 (fr) Nouveaux derives du benzo(4,5)cyclohepta(1,2-b)thiophene,leur preparation et leur utilisation comme medicaments
FR2523972A1 (fr) Derives vinyliques substitues de la 1h-pyrazolo-(1,5-a) pyrimidine utiles notamment comme medicaments antiulcerigenes et antisecretoires gastriques et procede de leur preparation